Premium
Axogen Inc (AXGN)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-08 | Ms. Amy A. McBride-WendellInitié | -1,65k | 45,70k | Derivative Exercise and Sale | 14,85 - 42,60 | 93,83k | - |
| 2026-05-07 | Mr. John H. JohnsonIndependent Director | -11,05k | 400,18k | Derivative Exercise and Sale | 7,04 - 43,26 | - | - |
| 2026-05-07 | Ms. Kathy WeilerIndependent Director | -16,34k | 607,03k | Derivative Exercise and Sale | 6,95 - 44,09 | - | - |
| 2026-05-07 | Mr. Jens Schroeder KempCMO | -4,00k | 173,76k | Vente | 43,44 | 72,45k | -5,23% |
| 2026-05-07 | Ms. Lindsey HartleyCFO | -1,05k | 37,24k | Derivative Exercise and Sale | 8,20 - 43,67 | 65,15k | - |
| 2026-05-07 | Ms. Lindsey HartleyCFO | 4,41k | 36,35k | Derivative Exercise and Retained Stock | 8,20 - 8,27 | 65,15k | 7,26% |
| 2026-05-07 | Ms. Doris QuackenbushVP of Sales | -3,88k | 168,72k | Vente | 43,51 | 92,42k | -4,03% |
| 2026-03-16 | Mr. Erick DeVinneyChief Innovation Officer | -8,09k | 265,71k | Derivative Exercise and Sale | 32,84 | 237,78k | - |
| 2026-03-16 | Mr. Erick DeVinneyChief Innovation Officer | 9,85k | 0,00 | Derivative Exercise and Retained Stock | - | 237,78k | 4,32% |
| 2026-03-16 | Ms. Lindsey HartleyCFO | -3,54k | 116,32k | Derivative Exercise and Sale | 32,84 | 60,73k | - |
| 2026-03-16 | Ms. Lindsey HartleyCFO | 5,46k | 0,00 | Derivative Exercise and Retained Stock | - | 60,73k | 9,87% |
| 2026-02-26 | Mr. Jens Schroeder KempCMO | -18,37k | 582,19k | Sale to Issuer | 30,65 - 31,90 | 76,45k | -19,37% |
| 2026-03-01 | Mr. Marc A. BeganExec. VP, General Counsel, Secretary & CCO | 6,82k | 0,00 | Derivative Exercise and Retained Stock | - | 50,14k | 15,75% |
| 2026-03-01 | Mr. Marc A. BeganExec. VP, General Counsel, Secretary & CCO | -4,43k | 135,69k | Derivative Exercise and Sale | 30,65 | 50,14k | - |
| 2026-02-26 | Mr. Marc A. BeganExec. VP, General Counsel, Secretary & CCO | -8,75k | 279,22k | Sale to Issuer | 31,90 | 50,14k | -14,86% |
| 2026-02-26 | Mr. Erick DeVinneyChief Innovation Officer | -21,98k | 687,00k | Sale to Issuer | 30,65 - 31,90 | 215,43k | -9,26% |
| 2026-02-26 | Ms. Lindsey HartleyCFO | -6,63k | 211,50k | Sale to Issuer | 31,90 | 55,28k | -10,71% |
| 2026-02-22 | Ms. Lindsey HartleyCFO | -6,70k | 237,19k | Sale to Issuer | 35,38 | 44,45k | -13,10% |
| 2025-12-15 | Ms. Lindsey HartleyCFO | -14,81k | 319,80k | Derivative Exercise and Sale | 8,27 - 29,86 | 31,38k | - |
| 2025-12-16 | Ms. Kathy WeilerIndependent Director | -40,07k | 903,89k | Derivative Exercise and Sale | 6,95 - 29,55 | - | - |
| 2025-12-16 | Ms. Kathy WeilerIndependent Director | -6,58k | 194,44k | Vente | 29,55 | 0,00 | -100,00% |
| 2025-12-16 | Ms. Amy A. McBride-WendellInitié | -43,68k | 978,50k | Derivative Exercise and Sale | 6,30 - 29,31 | 93,83k | - |
| 2025-12-11 | Mr. Marc A. BeganExec. VP, General Counsel, Secretary & CCO | -13,22k | 396,66k | Vente | 30,00 | 18,29k | -41,97% |
| 2025-12-10 | Mr. Michael D. DalePresident, CEO & Director | -25,00k | 750,00k | Vente | 30,00 | 63,54k | -28,24% |
| 2025-12-09 | Dr. Joseph TyndallIndependent Director | -25,11k | 558,55k | Derivative Exercise and Sale | 7,04 - 30,98 | 0,00 | - |
| 2025-12-09 | Mr. Michael D. DalePresident, CEO & Director | -61,46k | 1,92M | Vente | 31,21 | 88,54k | -40,98% |
| 2025-12-09 | Mr. Marc A. BeganExec. VP, General Counsel, Secretary & CCO | -9,28k | 289,55k | Vente | 31,21 | 31,51k | -22,75% |
| 2025-12-09 | Mr. Jens Schroeder KempCMO | -8,16k | 254,53k | Vente | 31,21 | 46,03k | -15,05% |
| 2025-12-09 | Mr. Erick DeVinneyChief Innovation Officer | -19,52k | 609,09k | Vente | 31,21 | 191,13k | -9,27% |
| 2025-12-08 | Ms. Lindsey HartleyCFO | 10,61k | 161,53k | Derivative Exercise and Retained Stock | 15,22 | 31,38k | 51,11% |
| 2025-12-08 | Ms. Lindsey HartleyCFO | -14,39k | 270,13k | Derivative Exercise and Sale | 8,20 - 31,56 | 31,38k | - |
| 2025-12-08 | Mr. John H. JohnsonIndependent Director | -20,44k | 498,72k | Derivative Exercise and Sale | 6,30 - 31,22 | 0,00 | - |
| 2025-12-08 | Mr. John H. JohnsonIndependent Director | -24,94k | 762,92k | Vente | 29,98 - 31,26 | 0,00 | -100,00% |
| 2025-12-09 | Mr. Paul G. ThomasIndependent Chairman of the Board | -21,40k | 633,71k | Vente | 29,61 | 0,00 | -100,00% |
| 2025-11-10 | Mr. William P. BurkeIndependent Director | -22,82k | 362,15k | Derivative Exercise and Sale | 8,14 - 24,02 | 100,00 | - |
| 2025-11-05 | Mr. William P. BurkeIndependent Director | -16,78k | 266,69k | Derivative Exercise and Sale | 8,14 - 24,05 | 100,00 | - |
| 2025-10-29 | Mr. William P. BurkeIndependent Director | -58,48k | 828,34k | Derivative Exercise and Sale | 6,30 - 23,00 | 100,00 | - |
| 2025-10-22 | Mr. William P. BurkeIndependent Director | -1,46k | 26,25k | Automatic Disposition | 18,02 | 100,00 | -93,58% |
| 2025-10-06 | Mr. William P. BurkeIndependent Director | -736,00 | 13,25k | Automatic Disposition | 18,00 | 1,56k | -32,10% |
| 2025-10-02 | Mr. William P. BurkeIndependent Director | -32,19k | 584,07k | Automatic Disposition | 18,01 - 18,21 | 2,29k | -93,35% |
| 2025-09-16 | Mr. Erick DeVinneyChief Innovation Officer | -1,14k | 18,52k | Vente | 16,29 | 170,65k | -0,66% |
| 2025-06-09 | Ms. Kathy WeilerIndependent Director | -4,07k | 43,21k | Vente | 10,61 | 6,58k | -38,23% |
| 2025-06-09 | Mr. Alan M. LevineIndependent Director | -4,07k | 43,21k | Vente | 10,61 | 36,74k | -9,98% |
| 2025-06-09 | Ms. Amy A. McBride-WendellInitié | -4,07k | 43,21k | Vente | 10,61 | 93,83k | -4,16% |
| 2025-06-09 | Mr. William P. BurkeIndependent Director | -4,07k | 43,21k | Vente | 10,61 | 24,48k | -14,26% |
| 2025-06-09 | Mr. Guido Julius NeelsInitié | -4,07k | 43,21k | Vente | 10,61 | 86,74k | -4,48% |
| 2025-06-09 | Mr. John H. JohnsonIndependent Director | -4,07k | 43,21k | Vente | 10,61 | 24,94k | -14,04% |
| 2025-06-10 | Dr. Joseph TyndallIndependent Director | -11,59k | 48,25k | Derivative Exercise and Sale | 6,30 - 10,72 | 0,00 | - |
| 2025-06-10 | Dr. Joseph TyndallIndependent Director | -15,35k | 164,50k | Vente | 10,72 | 0,00 | -100,00% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
